In the lymphoid lineage, besides VLA4, integrin beta1 (CD29) can form VLA5 in complex with α5, and α4 (CD49d) can bind β7 forming LPAM—both described in myeloma. Here, IGKV2D-26 is linked to plasma cell myeloma.